Barclays upgraded CVS Health Corp (NYSE:CVS) shares to Overweight from Equal Weight, citing a promising outlook for the company's margin recovery. The firm also raised its price target for CVS shares ...

A federal antitrust watchdog is already conducting an investigation into and has filed a lawsuit against huge pharmacy ...

Russell's Pharmacy & Shoppe's last day on Angier Avenue is October 19. Its closure comes as independent pharmacies around the ...

TD Cowen upgraded CVS Health (NYSE: CVS) to Buy from Hold, raising its price target to $85 from $59. This represents a ...

The companies argue the commissioners have "a lengthy track record of making public statements that indicate serious bias" ...

CVS Health (CVS) stock receives an upgrade from TD Cowen to Buy with a price target of $85, based on favorable Medicare ...

Whatever the outcome of the countering lawsuits, it will be a challenging period for PBMs, given the FTC's actions on alleged ...

Patients could feel the tension building behind the counter before ... “We knew it was an issue,” said CVS Pharmacy Manager Corey Spriggs. “But it kind of helped us put into focus how ...

Coho Partners, an investment management company released its “Relative Value Equity Strategy” second quarter 2024 investor ...

CVS Health (CVS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Charles Rhyee ...

CVS Health is set to lay off 2900 employees nationwide, primarily in corporate roles, as part of a $2 billion cost-saving ...

Today’s pharmacy innovations provide employees with expanded choices to meet their health care needs. As a result, they ...